Search Results - "Grebely, Jason"

Refine Results
  1. 1

    Epidemiology and natural history of HCV infection by Hajarizadeh, Behzad, Grebely, Jason, Dore, Gregory J.

    “…Globally, 130–170 million people have HCV infection; however, distribution patterns are highly variable. This Review outlines the latest information on the…”
    Get full text
    Journal Article
  2. 2

    Global patterns of opioid use and dependence: harms to populations, interventions, and future action by Degenhardt, Louisa, Grebely, Jason, Stone, Jack, Hickman, Matthew, Vickerman, Peter, Marshall, Brandon D L, Bruneau, Julie, Altice, Frederick L, Henderson, Graeme, Rahimi-Movaghar, Afarin, Larney, Sarah

    Published in The Lancet (British edition) (26-10-2019)
    “…We summarise the evidence for medicinal uses of opioids, harms related to the extramedical use of, and dependence on, these drugs, and a wide range of…”
    Get full text
    Journal Article
  3. 3

    Direct-acting antiviral agents for HCV infection affecting people who inject drugs by Grebely, Jason, Hajarizadeh, Behzad, Dore, Gregory J.

    “…Key Points HCV prevalence and incidence among people who inject drugs (PWID) remains high Direct-acting antiviral agents (DAA) for HCV with cure in >95%…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Global statistics on alcohol, tobacco and illicit drug use: 2017 status report by Peacock, Amy, Leung, Janni, Larney, Sarah, Colledge, Samantha, Hickman, Matthew, Rehm, Jürgen, Giovino, Gary A., West, Robert, Hall, Wayne, Griffiths, Paul, Ali, Robert, Gowing, Linda, Marsden, John, Ferrari, Alize J., Grebely, Jason, Farrell, Michael, Degenhardt, Louisa

    Published in Addiction (Abingdon, England) (01-10-2018)
    “…Aims This review provides an up‐to‐date curated source of information on alcohol, tobacco and illicit drug use and their associated mortality and burden of…”
    Get full text
    Journal Article
  6. 6

    Prevention, treatment and care of hepatitis C virus infection among people who inject drugs by Bruggmann, Philip, Grebely, Jason

    Published in The International journal of drug policy (01-02-2015)
    “…Abstract People who inject drugs (PWID) represent the core of the hepatitis C virus (HCV) epidemic in many countries. HCV transmission continues among PWID,…”
    Get full text
    Journal Article
  7. 7

    Global elimination of hepatitis C virus by 2030: why not? by Dore, Gregory J., Martinello, Marianne, Alavi, Maryam, Grebely, Jason

    Published in Nature medicine (01-02-2020)
    “…The World Health Organization’s targets for eliminating hepatitis C virus by 2030 have been deemed ambitious by many. However, we believe they are achievable,…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: A meta-analysis by Hajarizadeh, Behzad, Cunningham, Evan B., Valerio, Heather, Martinello, Marianne, Law, Matthew, Janjua, Naveed Z., Midgard, Håvard, Dalgard, Olav, Dillon, John, Hickman, Matthew, Bruneau, Julie, Dore, Gregory J., Grebely, Jason

    Published in Journal of hepatology (01-04-2020)
    “…HCV reinfection following successful treatment can compromise treatment outcomes. This systematic review assessed the rate of HCV reinfection following…”
    Get full text
    Journal Article
  10. 10

    Direct-acting antiviral treatment for hepatitis C among people who use or inject drugs: a systematic review and meta-analysis by Hajarizadeh, Behzad, Cunningham, Evan B, Reid, Hannah, Law, Matthew, Dore, Gregory J, Grebely, Jason

    Published in The lancet. Gastroenterology & hepatology (01-11-2018)
    “…There are concerns around poorer response to direct-acting antiviral (DAA) therapy for hepatitis C virus infection among people who use drugs. This systematic…”
    Get more information
    Journal Article
  11. 11

    Management of acute HCV infection in the era of direct-acting antiviral therapy by Martinello, Marianne, Hajarizadeh, Behzad, Grebely, Jason, Dore, Gregory J., Matthews, Gail V.

    “…The management of acute HCV infection has not been standardized following the availability of direct-acting antiviral agents (DAAs) for chronic HCV infection,…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Australia could miss the WHO hepatitis C virus elimination targets due to declining treatment uptake and ongoing burden of advanced liver disease complications by Kwon, Jisoo A, Dore, Gregory J, Hajarizadeh, Behzad, Alavi, Maryam, Valerio, Heather, Grebely, Jason, Guy, Rebecca, Gray, Richard T

    Published in PloS one (16-09-2021)
    “…Australia was one of the first countries to introduce government-funded unrestricted access to direct-acting antiviral (DAA) therapy, with 88,790 treated since…”
    Get full text
    Journal Article
  14. 14

    Mixed HCV infection and reinfection in people who inject drugs—impact on therapy by Cunningham, Evan B., Applegate, Tanya L., Lloyd, Andrew R., Dore, Gregory J., Grebely, Jason

    “…Key Points As a result of ongoing high-risk behaviours, people who inject drugs (PWID) might commonly harbour mixed HCV infections and are at risk of…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Deimplementation in the provision of opioid agonist treatment to achieve equity of care for people engaged in treatment: a qualitative study by Conway, Anna, Marshall, Alison D, Crawford, Sione, Hayllar, Jeremy, Grebely, Jason, Treloar, Carla

    Published in Implementation science : IS (09-06-2023)
    “…Deimplementation, the removal or reduction of potentially hazardous approaches to care, is key to progressing social equity in health. While the benefits of…”
    Get full text
    Journal Article
  17. 17

    Timely Hepatitis C RNA Testing and Treatment in the Era of Direct-Acting Antiviral Therapy among People with Hepatitis C in New South Wales, Australia by Yousafzai, Mohammad T., Alavi, Maryam, Valerio, Heather, Hajarizadeh, Behzad, Grebely, Jason, Dore, Gregory J.

    Published in Viruses (08-07-2022)
    “…This study aimed to identify the factors associated with timely (within four weeks) HCV RNA testing and timely (within six months) DAA initiation following HCV…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Estimating the number of people who inject drugs in Australia by Larney, Sarah, Hickman, Matthew, Guy, Rebecca, Grebely, Jason, Dore, Gregory J, Gray, Richard T, Day, Carolyn A, Kimber, Jo, Degenhardt, Louisa

    Published in BMC public health (29-09-2017)
    “…Injecting drug use is associated with considerable morbidity and mortality. Estimates of the size of the population of people who inject drugs are critical to…”
    Get full text
    Journal Article